SIGLEC8
Basic information
Region (hg38): 19:51450847-51458456
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIGLEC8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 29 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 2 | 3 |
Variants in SIGLEC8
This is a list of pathogenic ClinVar variants found in the SIGLEC8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-51452446-C-T | not specified | Uncertain significance (May 30, 2023) | ||
19-51452488-T-G | not specified | Uncertain significance (Jun 02, 2023) | ||
19-51452558-C-T | not specified | Uncertain significance (Dec 04, 2023) | ||
19-51452586-A-C | Benign (Jul 13, 2018) | |||
19-51452612-T-G | not specified | Uncertain significance (Jun 04, 2024) | ||
19-51454242-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
19-51454290-C-T | not specified | Uncertain significance (May 14, 2024) | ||
19-51454733-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
19-51455420-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
19-51455477-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
19-51455489-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
19-51455511-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
19-51455579-C-G | not specified | Uncertain significance (Sep 27, 2022) | ||
19-51455603-G-T | not specified | Uncertain significance (Dec 28, 2023) | ||
19-51455604-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
19-51455613-T-C | not specified | Likely benign (May 23, 2023) | ||
19-51455668-A-T | not specified | Uncertain significance (Mar 27, 2023) | ||
19-51457463-G-A | Benign (Jul 13, 2018) | |||
19-51457476-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
19-51457479-C-T | not specified | Likely benign (Jul 09, 2021) | ||
19-51457491-T-C | not specified | Uncertain significance (May 03, 2023) | ||
19-51457568-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
19-51457581-G-A | not specified | Uncertain significance (Apr 28, 2022) | ||
19-51457619-A-G | not specified | Uncertain significance (Apr 15, 2024) | ||
19-51457623-A-G | not specified | Uncertain significance (Jun 11, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SIGLEC8 | protein_coding | protein_coding | ENST00000321424 | 7 | 7610 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.22e-7 | 0.787 | 125621 | 0 | 125 | 125746 | 0.000497 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0824 | 274 | 278 | 0.986 | 0.0000151 | 3168 |
Missense in Polyphen | 64 | 66.506 | 0.96232 | 840 | ||
Synonymous | 0.479 | 116 | 123 | 0.945 | 0.00000703 | 1079 |
Loss of Function | 1.37 | 13 | 19.5 | 0.665 | 0.00000104 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000825 | 0.000825 |
Ashkenazi Jewish | 0.00744 | 0.00747 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000203 | 0.000202 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000230 | 0.000229 |
Other | 0.000655 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Putative adhesion molecule that mediates sialic-acid dependent binding to red blood cells (PubMed:10856141, PubMed:10625619). Preferentially binds to alpha-2,3-linked sialic acid. Also binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface (PubMed:10625619). Recognizes simultaneously epitopes having a terminal N-acetylneuraminic acid (sialic acid) and an underlying 6-O-sulfated galactose. Preferentially binds to Gal-6-sulfated sialyl-Lewis X glycan epitopes (PubMed:27357658). {ECO:0000269|PubMed:10625619, ECO:0000269|PubMed:10856141, ECO:0000269|PubMed:27357658}.;
- Pathway
- Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Intolerance Scores
- loftool
- 0.825
- rvis_EVS
- 0.6
- rvis_percentile_EVS
- 82.83
Haploinsufficiency Scores
- pHI
- 0.208
- hipred
- N
- hipred_score
- 0.158
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0733
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- cell adhesion;signal transduction
- Cellular component
- integral component of membrane
- Molecular function
- transmembrane signaling receptor activity;protein binding;carbohydrate binding